Cannabinoids for the treatment of dementia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cannabinoids for the treatment of dementia

Published:2021-09-17 Issue:9 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Bosnjak Kuharic Dina¹,Markovic Domagoj²,Brkovic Tonci³,Jeric Kegalj Milka⁴,Rubic Zana⁵,Vuica Vukasovic Ana⁶,Jeroncic Ana⁷,Puljak Livia⁸

Affiliation:

1. University Psychiatric Hospital Vrapče; Zagreb Croatia

2. Clinic for Heart and Cardiovascular Diseases; University of Split Hospital Center; Split Croatia

3. Division of Nephrology, Department of Internal Medicine; University of Split Hospital Center; Split Croatia

4. Department of Dermatovenerology; General Hospital Zadar; Split Croatia

5. Department of Clinical Microbiology; University of Split Hospital Center; Split Croatia

6. Department of Nuclear Medicine; University of Split Hospital Center; Split Croatia

7. Department of Research in Biomedicine and Health; University of Split School of Medicine; Split Croatia

8. Center for Evidence-Based Medicine and Health Care; Catholic University of Croatia; Zagreb Croatia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference158 articles.

1. Randomized placebo-controlled trial of nabilone for agitation in Alzheimer's disease;Herrmann;American Journal of Geriatric Psychiatry,2019

2. Safety and efficacy of nabilone in Alzheimer's disease: a pilot study https://clinicaltrials.gov/show/NCT02351882

3. Ruthirakuhan M Herrmann N Abraham EH Sherman C Verhoeff NPLG Kiss A A randomized, placebo-controlled, cross-over trial investigating nabilone as a treatment for agitation in patients with moderate-to-severe Alzheimer's disease: blinded, interim safety results Alzheimer's & Dementia: Journal of the Alzheimer's Association 2017 1254 10.1016/j.jalz.2017.06.1867

4. 24S-Hydroxycholesterol is associated with agitation severity in patients with moderate-to-severe Alzheimer's disease: analyses from a clinical trial with nabilone;Ruthirakuhan;Journal of Alzheimer's Disease,2019

5. Agitation, oxidative stress, and cytokines in Alzheimer disease: biomarker analyses from a clinical trial with nabilone for agitation;Ruthirakuhan;Journal of Geriatric Psychiatry and Neurology,2020

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alzheimer's disease approaches - Focusing on pathology, biomarkers and clinical trial candidates;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-08

2. Potential Biomarkers in Cerebrospinal Fluid and Plasma for Dementia;Journal of Alzheimer's Disease;2024-07-16

3. Road hazard: a systematic review of traffic injuries following recreational cannabis legalization;Canadian Journal of Emergency Medicine;2024-07-01

4. Cannabinoids’ Role in Modulating Central and Peripheral Immunity in Neurodegenerative Diseases;International Journal of Molecular Sciences;2024-06-10

5. ESPEN guideline on nutrition and hydration in dementia – Update 2024;Clinical Nutrition;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3